Fasudil, a Rho-Kinase Inhibitor, Exerts Cardioprotective Function in Animal Models of Myocardial Ischemia/Reperfusion Injury: A Meta-Analysis and Review of Preclinical Evidence and Possible Mechanisms

Fasudil, a Rho-kinase inhibitor, has shown outstanding therapeutic effects against cerebral vasospasm after subarachnoid hemorrhage (SAH) in humans. Studies show various biological effects of fasudil in the cardiovascular system. We conducted a preclinical systematic review to determine the efficacy...

Full description

Saved in:
Bibliographic Details
Main Authors: Yue-yue Huang (Author), Jian-ming Wu (Author), Tong Su (Author), Song-yue Zhang (Author), Xiao-ji Lin (Author)
Format: Book
Published: Frontiers Media S.A., 2018-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_0eb1f1a2b1a24f10b7158d8b5418f06d
042 |a dc 
100 1 0 |a Yue-yue Huang  |e author 
700 1 0 |a Jian-ming Wu  |e author 
700 1 0 |a Tong Su  |e author 
700 1 0 |a Song-yue Zhang  |e author 
700 1 0 |a Xiao-ji Lin  |e author 
245 0 0 |a Fasudil, a Rho-Kinase Inhibitor, Exerts Cardioprotective Function in Animal Models of Myocardial Ischemia/Reperfusion Injury: A Meta-Analysis and Review of Preclinical Evidence and Possible Mechanisms 
260 |b Frontiers Media S.A.,   |c 2018-10-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2018.01083 
520 |a Fasudil, a Rho-kinase inhibitor, has shown outstanding therapeutic effects against cerebral vasospasm after subarachnoid hemorrhage (SAH) in humans. Studies show various biological effects of fasudil in the cardiovascular system. We conducted a preclinical systematic review to determine the efficacy and possible mechanisms of fasudil on animal models of myocardial ischemia/reperfusion (I/R) injury. Nineteen studies involving 400 animals were identified after searching 8 databases for articles published till June 2018. The methodological quality was assessed by the Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies (CAMARADES) 10-item checklist. The data were analyzed using Rev-Man 5.3 software, and the score of study quality ranged from 3 to 6 points. Compared to the control group, fasudil treated animals showed reduced myocardial infarct size (P < 0.05), lower levels of cardiac enzymes (P < 0.05) and cardiac troponin T (P < 0.05), improved systolic and diastolic functions (P < 0.05), and increased degree of decline in the ST-segment (P < 0.05). The possible mechanisms of fasudil action against myocardial I/R injury are improvement in coronary vasodilation, inhibition of apoptosis and oxidative stress, relieving inflammation, and reduction in endoplasmic reticulum stress and metabolism. In conclusion, fasudil exerts a cardio-protective function through multiple signaling pathways in animal models of myocardial I/R injury. 
546 |a EN 
690 |a fasudil 
690 |a myocardial ischemia/reperfusion injury 
690 |a efficacy 
690 |a mechanisms 
690 |a meta-analysis 
690 |a systematic review 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 9 (2018) 
787 0 |n https://www.frontiersin.org/article/10.3389/fphar.2018.01083/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/0eb1f1a2b1a24f10b7158d8b5418f06d  |z Connect to this object online.